HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study
ConclusionsStatin treatment had a modest negative association with COVID-19 mortality. While this finding needs confirmation from randomized clinical trials, it supports the continued use of statin treatment for medical prevention according to current recommendations also during the COVID-19 pandemic.
Source: PLoS Medicine - Category: Internal Medicine Authors: Rita Bergqvist Source Type: research
More News: Cardiology | Cholesterol | Clinical Trials | Coronavirus | COVID-19 | Education | Heart | Heart Disease | Internal Medicine | Pandemics | Statin Therapy | Study | Sweden Health | Universities & Medical Training